Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Clinical trial

Transabdominal Fetal Reduction in Higher Order Multiple Pregnancies - a Pioneer Study in Nepal

ID
Name
20/2020
Description
Multifetal pregnancies are common in in vitro fertilization. Multifetal gestation increases maternal and fetal morbidity and mortality. We perform fetal reduction in our hospital by intra-thoracic injection of potassium chloride. This manuscript is description of our initial experience.
Trial arms
Trial start
2018-02-01
Estimated PCD
2023-04-30
Trial end
2023-04-30
Status
Completed
Treatment
Fetal Reduction
Under ultrasound guidance, intracardiac injection of 0.2 to 3.0 ml of 15% weight/volume (2 miliequivalent/mililiter ) potassium chloride (KCl) was administered via transabdominal route
Other names:
Selective fetal reduction
Size
108
Primary endpoint
Transabdominal ultrasonography guided fetal reduction is safe and effective in first trimester
4.5 years
Eligibility criteria
Inclusion Criteria: * pregnant females with multifetal gestation who opt to undergo fetal reduction Exclusion Criteria: * who do not give consent
Protocol
{'studyType': 'OBSERVATIONAL', 'patientRegistry': False, 'designInfo': {'observationalModel': 'COHORT', 'timePerspective': 'RETROSPECTIVE'}, 'enrollmentInfo': {'count': 108, 'type': 'ACTUAL'}}
Updated at
2024-02-09

1 organization

1 product

1 indication

Organization
Grande International Hospital
Product
Fetal Reduction
Indication
In Vitro Fertilization